This company seems to have been delisted
Reason: Filed for chapter 11 bankruptcy
Last recorded trade on: March 12, 2024
Source: https://www.fiercebiotech.com/biotech/athersys-files-bankruptcy-sells-assets-healios-wake-roke-cell-therapys-struggles
Reason: Filed for chapter 11 bankruptcy
Last recorded trade on: March 12, 2024
Source: https://www.fiercebiotech.com/biotech/athersys-files-bankruptcy-sells-assets-healios-wake-roke-cell-therapys-struggles
Athersys
ATHX
A$0.02072
Share price
-33.50%
Change (1 day)
-98.90%
Change (1 year)
Categories
Athersys (ATHX) - Net assets
Net assets on the balance sheet as of September 2023 : -A$55.86 Million
According to Athersys's latest financial reports the company has -A$55.86 Million in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Athersys - Net assets on balance sheet (from 2005 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2022-12-31 | $-A$35.05 Million | -255.23% |
| 2021-12-31 | $A$22.57 M | -44.64% |
| 2020-12-31 | $A$40.78 M | 22.71% |
| 2019-12-31 | $A$33.23 M | -45.69% |
| 2018-12-31 | $A$61.2 M | 104.4% |
| 2017-12-31 | $A$29.94 M | 93.03% |
| 2016-12-31 | $A$15.51 M | -42.71% |
| 2015-12-31 | $A$27.07 M | 6.05% |
| 2014-12-31 | $A$25.53 M | 14.9% |
| 2013-12-31 | $A$22.22 M | 14.05% |
| 2012-12-31 | $A$19.48 M | 173.73% |
| 2011-12-31 | $A$7.11 M | -19.71% |
| 2010-12-31 | $A$8.86 M | -57.99% |
| 2009-12-31 | $A$21.1 M | -52.83% |
| 2008-12-31 | $A$44.73 M | -17.88% |
| 2007-12-31 | $A$54.48 M | -8404569.06% |
| 2006-12-31 | $-A$0.01 Million | -147.43% |
| 2005-12-31 | $A$0 M | 5.76% |
| 2004-12-31 | $A$0 M | -99.99% |
| 2003-12-31 | $A$20.11 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Amgen AMGN | A$9.52 B | -17,154.54% | 🇺🇸 USA |
 Pfizer PFE | A$139.09 B | -249,136.96% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | A$26.77 B | -48,040.65% | 🇺🇸 USA |
 Moderna
MRNA | A$15.44 B | -27,757.65% | 🇺🇸 USA |
 Johnson & Johnson JNJ | A$119.86 B | -214,714.64% | 🇺🇸 USA |
 United States Lime & Minerals USLM | A$0.81 B | -1,562.31% | 🇺🇸 USA |
 Merck MRK | A$74.27 B | -133,085.30% | 🇺🇸 USA |
 Sanofi SNY | A$123.55 B | -221,317.20% | 🇫🇷 France |